This inventor holds 1 USPTO granted patent. Top assignee: Universitéde Montreal. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: The Innovative Contributions of Stephane Buczkowski
Introduction
Stephane Buczkowski is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of drug delivery systems. His innovative approach has led to advancements that enhance the efficacy of medication administration.
Latest Patents
Buczkowski holds a patent for "Substituted amylose as a matrix for sustained drug release." This invention involves a pharmaceutical sustained release tablet designed for oral administration. The tablet is composed of a compressed blend of at least two dry powders, including a pharmaceutical drug and a sustained release matrix. The matrix is made from substituted amylose, which is prepared by reacting amylose with an organic substituent in a basic medium. This method allows for a controlled and sustained release of the drug, achieving a close-to-linear release profile over a period of 9 to 20 hours. He has 1 patent to his name.
Career Highlights
Buczkowski is affiliated with the Université de Montréal, where he continues to engage in research and development. His work focuses on improving drug delivery systems, which is crucial for enhancing patient outcomes in pharmaceutical care.
Collaborations
Throughout his career, Buczkowski has collaborated with esteemed colleagues, including Louis Cartilier and Iskandar Moussa. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas.
Conclusion
Stephane Buczkowski's contributions to the field of pharmaceuticals through his innovative patent demonstrate his commitment to advancing drug delivery systems. His work not only reflects his expertise but also has the potential to significantly impact patient care.